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Medicine is a learned profession that has its own intrinsic ethic. Under this
intrinsic ethic, the end of medicine is ordered to a good that is health.
Technique and conduct are not value-neutral but rather are ordered to this
overarching good that is the nature-given end of health. Medicine is a
profession precisely because it professes such a goal. Being a professional
is more than being a technician. The public profession of medicine as a
way of life is an affirmation of the moral nature of our activity. Medicine
as a profession is a public declaration of a willingness to devote oneself to
others and to serve a higher good. The physician is a moral being who
professes and affirms the moral nature of his activity.
We have in recent years seen an attempt to convert our profession
into a killing activity. Doctors as abortionists kill unbcfm children; doctors
accept the responsibility to kill patients with or without their consent as in
Holland, or to engage in the subterfuge of physician-assisted suicide, as in
the state of Oregon in America. The doctor true to his calling will not
violate the taboo against killing. He will not do it for love and he will not
do it for money.
This is why medicine must be a profession and not merely a
business. A physician who is guided primarily by the profit motive will
have conceded that he is willing to sacrifice the best interests of his patient
in the patient's pursuit of health.
Recently there has been an erosion of some of the safeguards that
have accrued to the protection of the patient and the society.
Let us start with information published in medical journals. This
information helps to shape diagnostic and therapeutic decisions . For a
medical journal to be of value, it must publish authoritative, up-to-date
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information that is free of commercial influence. This requires that the
financial associations of authors are disclosed and that these associations
do not influence published articles. This is the only way to avoid bias or
the appearance of bias based on a conflict of interest. Beyond the authors
themselves, this freedom from conflict of interest must extend into the
process of peer review. If those who are assisting the editor in selecting
articles suitable for publication are not also free from similar financial
associations, the possibility of bias is reinforced. I Relationships between
biomedical companies and research are growing rapidly. Beyond the direct
support of research or therapeutic trials, authors may receive consulting
fees, serve on advisory boards, own equity, receive patent royalties or
receive honoraria for lectures or expert testimony.
Recently the New England Journal of Medicine 2 and, by inference3
the Journal of the American Medical Association, have altered their
policies so that authors of original articles as well as review atticles and
editorials will not have any "significant" financial interest in a company (or
its competitors) that makes a product discussed in an article. The National
Institutes of Health4 and the Association of American Medical Colleges5
have likewise relaxed their requirements regarding financial association
and resultant possible bias. The attempt has been made to quantitate what
degree of association could produce bias. The key provision is to set an
upper limit on the annual sum received by an author in order to have a
relationship considered "significant." Currently $10,000 is the de minimus
level. Beyond this, any holding in which the potential for profit is not
limited, such as stock, stock options or patent holdings, would probably be
disqualifying.
The justification for these changes in policy is said to be an inability
to impanel an adequate number of authors and/or reviewers to carry out the
functions of the journal because so many academicians ~nd clinicians are
involved in intertangling financial relationships with pharmaceutical
companies. 5• 6
Inevitably the outcome of the policy will be an enhanced opportunity
for the introduction of conflict of interest and a reduced confidence in the
reliability of published data. This will extend not only to decision making
by physicians and researchers but also to the general public. Almost every
major media outlet in the United States has a science editor and staff that
cover current medical literature, often counting on summaries and releases
published for their edification by the journals themselves. Providing this
service is a large source of income, for example, to the American Medical
Association.
Let us take one example. An article in the New England Journal on
RU-486 (Silvestre L. et al. New Eng J Med 322:645, 1990) concluded that
RU-486 was "effective and safe." Those who thought the data to be
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excessively sanguine and reassuring could be forewarned by the revelation
in a prominent place that all six authors were employees of Roussel-Uclef,
which manufactured RU-486 and stood to make huge profits from sales.
The knowledge that the so-called "scientific" article was in fact an illdisguised promotional piece could result in a healthy cynkism on the part
of readers. Not only was the unfounded enthusiasm promoted as factual by
the manufacturer, but also by the entire publicity apparatus of the proabortion lobby and its media collaborationists.

Concerns Regarding Bias
A delegation from the Catholic Medical Association met with the
executive director and the editorial staff of the lAMA to express our
concern that during the previous three years approximately fifteen proabortion articles were published and not one anti-abortion paper. Editorial
bias was vehemently denied. Subsequently, however, we came into
possession of an internal memorandum 7 leaked to us by an AMA employee
informing the editorial staff of lAMA that, in fact, their policy was as
demonstrated, that is, not to publish anti-abortion studies or statistical
studies unfavorable to abortion.
If this ideological bias is now to be augmented by a potential for bias
based on economic gain, the profession and the public will have been
thoroughly compromised.
President Bush was recently called upon to make a Solomonic
decision regarding stem cell research. While by no means a perfect
decision, it did make the important distinction between embryonic stem
cells (produced from embryos created for the purpose of being killed to
harvest their stem cells) and stem cells produced from adult sources
(umbilical cord blood, bone marrow, etc.). While forbidding federal
funding of the creation of any new embryonic stem cell lines the president
did concede, in his policy, the continuation of existing cell lines from
embryos. These were the fruit of a poisoned tree and, since adult stem cells
had outperformed embryonic stem cells both clinically and in the
laboratory, it was difficult to comprehend the dogmatic insistence by the
scientific community of the superiority of and need for embryonic cell
lines.
It turned out that many of the existing embryonic cell lines that were
allowed to be preserved were in fact owned by universities and other
enterprises that had every intention of profiting from the propagation of
and distribution of embryonic stem cells for research.
During the debate on cloni ng 8 in the U.S. Congress, it was revealed
that three human cloning patents were pending in the U.S. patent office.
The sponsor of the Human Cloning Prohibition Act, Senator Brownback,

,
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pointed out that the notion that we have to kill one person in order to find a
cure for another is a false tradeoff which disregards advances made in other
non-embryonic stem cell sources. Even more frightening is the prospect of
people in corporate America owning, trading, buying, and selling people
(clones) as if they were property. This is an issue that must be included in
the cloning debate. When Senator Brownback introduced a Human
Unpatentability Amendment to outlaw patenting human clones, it was
defeated. 9 This occurred on the same day that a team from the University
of Minnesota reported on the versatility of adult stem cells and their ability
to convert and morph into hundreds of specialized cells within the body. 10
Jonathan Swift said, "Falsehood flies and the truth comes lingering
after, so that when men come to be undeceived the jest is over and the tale
has had its effect." The culture of death has for the last thirty years clearly
controlled the press and the media now shows a sinister proclivity toward
controlling the scientific literature and thereby the political process.
Through the powerful incentive of the profit motive derives the clear
conflict of interest between objective scientific investigation and advocate
science in pursuit of monetary gain.
The ultimate perversion of the commercialism of medical research
would be the sale of body parts for use in experimentation. The reality of a
brisk business in fetal body parts has been exposed by numerous
investigative pro-life agencies . This offshoot of the abortion industry has
been demonstrated to advertise the availability of organs from aborted
babies in scientific journals. These are not merely allegations but are truly
undeniable since actual advertisements containing price lists for human
tissues have been exposed. Such offerings as "fetal liver, second trimester
fetal kidney, pancreatic islet tissue," each with an attached price list have
been discovered, (having been placed by so-called laboratories doing
business with abortionist sources.). I I
•
A movement is currently underway to approve the payment by
potential recipients for donor organs. Currently the National Organ
Transplant Act makes it illegal for "any person to knowingly acquire,
receive or otherwise transfer any human organ for valuable consideration
for use in human transplantation." The American Medical Association has
called for a study of the possibility of paying donors for organs. 12 The
background for this consideration of a radical policy change is, of course,
the annual shortfall in the availability of donor organs. The United
Network for Organ Sharing database indicates that there are now 75,000
patients waiting for an organ. Among those waiting for a heart or liver
transplant one-third will die before an organ becomes available.
The primary source of donor organs will be the so-called Heart
Beating Cadaver Donors. These are patients who have had an irreversible
cessation of total brain function and are being maintained on ventilators in
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intensive care units. These will constitute a pool of 10,000-12,000 potential
donors per year. Despite extensive public awareness campaigns, the ratio
of actual to potential donors has not increased sufficiently. 13 One response
has been a greater reliance on living donors (kidneys), partial transplants
(liver and lungs) and sources of dubious ethical propriety such as
anencephalic infants and animals.14
Another potential source of transplantable organs is patients who
have been declared dead by traditional cardiopulmonary rather than brainbased criteria. The success of transplants using organs from these sources
has been limited by problems with warm ischemia. These non-Heart
Beating Cadaver Donors fall generally into two categories: 1)
Uncontrolled Cardio-Pulmonary Death (usually in emergency rooms) and
2) Controlled Timing and Place of Death. This second category follows a
method commonly known as the Pittsburgh protocol. 15
Under this protocol, families who have decided to forego life support
are approached to donate organs. Warm ischemia time is minimized by
taking the patient to the operating room, disconnecting life support there,
and removing organs immediately or shortly after the pronouncement of
death. Ethical issues surrounding the use of Non-Heart Beating Cadaver
Donors have to do with the consent process, the question of irreversibility
and early declaration of death. There are also intuitive problems related to
the fact that the procedure seems staged or contrived in that the patient is
declared dead after having been removed from the company of his near
relatives and into an operating room.
Market forces have begun to erode the standard of uncompensated
donation from living donors by the opportunity to obtain organs outside the
United States. AmeIicans are purchasing organs from strangers in China,
Peru, and the Philippines and then returning to the U.S. for posttransplantation care. 16
'
Another challenge to the altruistic principles underlying the Act is
the increased frequency of kidney donations by patients unrelated to the
recipients since a close genetic match is no longer as necessary. The
possibility exists of illegal purchase and illegal profits beyond the control
of transplantation centers. 17
The movement to liberalize the rules to allow for a freer market in
the purchase of organs raises the specter of a bidding war in which less
deserving wealthy candidates for transplantation gain priority over poor
candidates lacking the wherewithal to purchase organs. One economist has
suggested that less affluent individuals could always take out loans to
purchase organs as they now do to purchase automobiles or houses. What
happens, however, if the borrower is incapable of repaying the loan? Can
we have some mechanism for foreclosing on or repossessing a kidney?
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The present system of providing ethical or humanitarian incentives
for donation would protect the unbiased distribution of organs based on
priority of need.! S
Brokering criteria in the United States would be impossible to
control. If the current prohibition against the sale of organs were
rescinded, there would be no legal justification for preventing persons from
bypassing the regulated system to compete in an unregulated market. The
potential unfairness of such a market and the preferability of enhanced
ethical incentives (public recognition, compensation of funeral expenses or
tax credits) would be the better way to sustain broad societal interest.! 9

Bioterrorism
Finally, a world of bioterrorism, a fundamental conflict of interest
has arisen over the issue of whether biologists should publish work that
could be rnisused. The National Academy of Sciences has set up a panel to
study how to prevent the destructive applications of advanced
biotechnology.20 Recent studies on the 1918 pandemic influenza virus at
the Armed Forces Institute of Pathology have suggested the potentials for
reconstructing the 1918 virus and making it more resistant to the immune
system. 2! Similar studies have been published to demonstrate how to
engineer microorganisms to spread more readily, resist antibiotics and
vaccines and thus be more effective as weapons for bioterrorism. There are
serious questions as to whether such information should be made available
in journals. A conflict of interest has arisen between bioweapons experts in
the government and the American Society of Microbiology as to whether
there should be special peer review. Needless to say, scientists are highly
resistant to the notion that their work or any importan, data should be
subject to censure for political reasons.
Though the conflicts of interest may not be as demonstrable in a
socialized medical system as they are in a capitalist system, they are
unavoidable in a privately based system either fee for service or managed
care. The main protection against the intrusion of political and economic
issues into medical care is a return to the Hippocratic system of medical
ethics that remains viable in all cultures and all forms of reimbursement.
Finally, another opportunity for conflict of interest consists of socalled "advocate science." This consists in the propounding of so-called
"scientific" claims or rejecting counterclaims based not on the quality of
objective data involved but rather on a hidden political agenda or a desire
for political correctness.
The principal occasion for the employment of advocate science is in
research regarding the etiology and the treatment of homosexuality or
same-sex attraction disorder. The media have promoted the idea that a
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"gay gene" has already been discovered and certain professional
organizations have not discouraged this assumption. If same sex attraction
were genetically determined, then one could expect identical twins to be
identical in their sexual attractions. Most studies, however, show that
identical twins are discordant in their sexual attraction. 22 , 23, 24
There are, however, ongoing attempts to convince the public that
same sex attraction is genetically based. Such attempts are politically
motivated by the supposition that the public would be more likely to
respond to changes in laws and religious teaching were they to believe that
same sex attraction is genetically determined and unchangeable.
A similar controversy surrounds the issue as to whether the
homosexual state is treatable and changeable. In the debate between
essentialism and social constructionism, the believer in natural law would
hold that human beings have an essential nature - either male or female and that sinful inclinations such as the desire to engage in homosexual acts
are constructed and can, therefore, be deconstructed. Some members of
the American Psychiatric Association have gone so far as to allege that
attempts to change homosexuals are not only unsuccessful but even
unethical. There are a number of therapists however, who have written
extensively that reparative therapy is successful with about 30%
experiencing a freedom from same sex attraction and another 30%
improvement. 25 , 26. 27, 28 Dr. Robert Spitzer, the renowned Columbia
University psychiatric researcher, who was largely responsible for the
removal of homosexuality from the APA's list of mental disorders, has now
indicated that his most recent research indicates that sustained change can
be achieved. 29
Other examples of advocate science would include, fIrst, the
American Cancer Society's refusal to admit a relf1tionship between
abortion and breast cancer,30 despite overwhelming evidence and, second,
the insistence of the National Institutes of Health on the effectiveness of the
condom in preventing AIDS. When the question was posed at a large
international meeting of AIDS experts as to how many would be willing to
have sexual intercourse with an HIV positive person while wearing a
condom, no one in the audience raised their hand. 31 The evidence strongly
suggested that the officialdom of numerous professional organizations,
such as AMA and American College of Obstetrics and Gynecology, has a
hidden agenda of apologizing for abortion and upholding the homosexual
rights lobby despite any evidence to the contrary and despite the
conflicting opinion of many in their grass roots membership.

24

Linacre Quarterly

References
1. D. Parrish & D. Bruns, "Legal Principles and Confidentiality in Peer Review,"
lAMA 287:2839 (2002).

2. J. Drazen & G. Curfman, "Financial Associations of Authors," N Eng 1 Med
346:1901 (2002) .
3. D. Rennie et aI., "Conflicts of Interest in the Publication of Science," lAMA
266:266 (1991).
4. Public Health CFR42, May 21 , 2002.
5. Task Force on Financial Conflicts of Interest in Clinical Research, Assoc. of
American Medical Colleges (December, 2001) .
6. M. Angell & A. Wood, "Authors' Conflicts of Interest," N Eng 1 Med, 341:1618
(1999).
7. Memorandum regarding topics for publication, G. Lundberg to Staff, Unpublished.
8. Human Cloning Prevention Act, S. Brownback, M . Landrien, and J. Ensign
sponsors, U.S. Senate.
9. Human Un-Patentability Amenment, S. Brownback (R - KS), Sponsor.
10. C. Verfaille, "Adult Stem Cells," Nature (June 15,2002).
11 .Life Dynamics, Denton, TX, Unpublished data.

•

12. "AMA : Study Paying for Organ Donation," Chicago Tribune, Page 4 (June 10,
2002).
13. E.F. Diamond, "Ethical Issues in the Use of Asystolic Donors," Linacre Quarterly
69:33 (2002).
14. E.F. Diamond, "Anencephalic Donors," Chicago Medicine 97: 15 (1994).
15. Policy for Management of Terrninally TIl Patients, U of Pittsburgh (April 2, 1992).
16. N . Scheper-Hughes, "The Global Traffic in Organs," Current Anthropology 41: 191
(200) ).
17. M . Friedlander, "The Right to Sell or Buy a Kidney," Lancet 359:971 (2002).

February, 2005

25

18. T. Delmonico et aI., "Ethical Incentives for Organ Donation," N Eng J Med
346:2002 (2002).
19. D. Levine, "Kidney Vending, Yes or No?," Am J Kidney Dis 35:1002 (2000).
20. "Speak No Evil," U.S. News and World Report (June 24, 2002), p. 60.
21. J. Taubenberger et a!., Proceedings of the National Academy of Sciences, On-line
(August 5,2002).
22. J. Bailey, R. Pillard, "A Genetic Study of Male Sexual Orientation," Archives of
General Psychiatry 48: 1089 (1996).
23. E. Eckert et a!., "Homosexuality in Monozygotic Twins Raised Apart," British J of
Psychiatry 148:421 (1986).
24. R. Friedman et aI., "Psychological Development and Blood Levels of Sex Steroids
in Male Identical Twins of Divergent Sexual Orientation," J of American Academy of
Psychoanalysis 8:427 (1980).
25 . J. Buber and T. Buber, "Male Homosexuality," Canadian J of Psychiatry 24:409
(1979).
26. H. McIntosh, "Attitudes and Experience of Psychoanalysts," J. of American
Psychoanalytic Assoc 42:1183 (1994).
27. J. Nicolois et aI., Toward the Ethical and Effective Treatment of Homosexuality,
(Narth, 1998).
28. J. Satinover, Homosexuality and the Politics of Truth (Baker,Books: Grand Rpaids,
MI,1996).
29. R. Spitzer, Communication (Narth (2000).
30. J. Brind et aI., "Induced Abortion and the Risk of Breast Cancer," N Eng J Med
336: 1834 (1997).
31. R. Redfield, Personal Communication (1999).

26

Linacre Quarterly

